跳至主要内容
临床试验/EUCTR2012-005803-42-SE
EUCTR2012-005803-42-SE进行中(未招募)不适用

Evaluation of platelet function following cessation of ticagrelor - a study in patients with acute coronary syndrome and PCI with coronary stent

niversitetssjukhuset Örebro0 个研究点开始时间: 2013年1月31日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. 12 months (+/- one week) treatment with double platelet blockade in the form of ASA and ticagrelor following PCI
  • 2. Age = 45 years
  • 3. Signed and dated Informed Consent
  • 4. The subject is willing and judged capable of following the protocol throughout the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • 1. Resistance against ticagrelor treatment (so-called non-responders”)
  • 2. Other oral anti-platelets agents other than ticagrelor 180 mg and ASA 75 mg/day
  • 3. Concurrent treatment with fluvoxamine, fluoxetine, moklobemide, voriconazole, fluconazole, ticlopidine, ciprofloxacin, cimetidine, carbamazepine, oxkarbazepine or chloramphenicol.
  • 4. Oversensitivity/allergy to ticagrelor
  • 5. Pregnancy or breastfeeding

研究者

发起方
niversitetssjukhuset Örebro

相似试验